
Zen Life Sciences Private Limited
Pharmaceutical company distributing oncology and critical care products, incorporated in 2008.
Pharmaceutical company distributing oncology and critical care products, incorporated in 2008.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U85190MH2008PTC188384
188384
Private Limited Indian Non-Government Company
21 Nov 2008
30 Sep 2022
31 Mar 2022
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mehul Jayant ![]() | Director | 21-Nov-2008 | Current |
Yogesh Navnitlal ![]() | Director | 21-Nov-2008 | Current |
Zen Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2022, Zen Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Zen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zen Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Zen Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Zen Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai.
Mehul Parekh Jayant was appointed as a Director was appointed as a Director on 21 Nov 2008 & has been associated with this company since 16 years 3 months .
Yogesh Parikh Navnitlal was appointed as a Director was appointed as a Director on 21 Nov 2008 & has been associated with this company since 16 years 3 months .
Zen Life Sciences Private Limited was registered on 21 Nov 2008 with Roc Mumbai & aged 16 years 3 months as per MCA records.
Zen Life Sciences Private Limited was incorporated on 21 Nov 2008.
The authorized share capital of Zen Life Sciences Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Zen Life Sciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Zen Life Sciences Private Limited is E/501 Sky Park Chs Ltd Oshiwara Garden Road Next To Hdfc House Off. S.V.Road, Goreg Aon - West India, Mumbai, Maharashtra, 400104.
The corporate identification number (CIN) of Zen Life Sciences Private Limited is U85190MH2008PTC188384 and the company number is 188384 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Zen Life Sciences Private Limited was filed with the ROC on 31 Mar 2022.
Search company & director profiles for free and gain access to critical business data.
SP